Stocks · Korea 086820 KOSDAQ

Bio Solution

6,760원 -0.15% Market cap 1,752억 2026-10-07 close

📈 Chart & live quote

Data as of 2026-10-07 · Linked from 6 pages

An overview for this page is not available in English yet. The figures below are updated daily.

Key figures 2026-10-07 basis

PER614.55x

PBR5.11x

EPS11 KRW

BPS1,324 KRW

ROE1.56%

Dividend yield0.00%

DPS0 KRW

Payout ratio0.00%

Returns and 52-week range

1W+2.12%

1M+10.69%

3M+13.87%

6M-46.25%

1Y-23.52%

YTD-19.98%

52W high13,450원

52W low5,240원

From 52W high-49.96%

Financial results (consolidated)

Period	Revenue	Operating income	Net income	OP margin
2025	152억	-43억	3억	-28.6%
Quarterly
2021 1Q	25억	-5억	-54,492,614원	-18.4%
2025 2Q	31억	-14억	-10억	-44.0%
2025 3Q	45억	-11억	-19억	-24.4%
2026 1Q	38억	-13억	-20억	-34.5%

Company

CEO이정선

Founded2000-01-14

Fiscal year end12

Websitewww.biosolutions.co.kr/

Address: 서울특별시 노원구 공릉로 232 5층 (공릉동, 서울테크노파크)

Peers in the same sector

Company	Market cap	P/E	P/B	1M
나이벡	1,827억	38.63	3.99	+6.42%
JW생명과학	1,732억	5.92	0.77	-2.32%
셀비온	1,827억	—	7.97	+17.90%
JW신약	1,603억	11.67	3.92	-16.62%
대원제약	1,850억	—	0.66	+3.25%
동화약품	1,567억	17.92	0.41	+7.88%

Recent filings

2026-08-14반기보고서 (2026.06)
2026-08-06[기재정정]주요사항보고서(전환사채권발행결정) Major
2026-05-15분기보고서 (2026.03)

Source: DART (Financial Supervisory Service electronic disclosure)

Sources and notes

This page summarizes public filings, market data and news for information only. It is not a recommendation to buy or sell any security. Figures are as of the dates shown; check the original filings before making decisions.